SEARCH

SEARCH BY CITATION

References

  • Abderrahmani A., Niederhauser G., Plaisance V., Haefliger J. A., Regazzi R. and Waeber G. (2004) Neuronal traits are required for glucose-induced insulin secretion. FEBS Lett. 565, 133138.
  • Andermann E., Remillard G. M., Goyer C., Blitzer L., Andermann F. and Barbeau A. (1976) Genetic and family studies in Friedreich's ataxia. Can. J. Neurol. Sci. 3, 287301.
  • Anderson P. R., Kirby K., Orr W. C., Hilliker A. J. and Phillips J. P. (2008) Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia. Proc. Natl Acad. Sci. USA 105, 611616.
  • Armstrong J. S., Khdour O. and Hecht S. M. (2010) Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. FASEB J. 24, 21522163.
  • Ashby D. W. and Tweedy P. S. (1953) Friedreich's ataxia combined with diabetes mellitus in sisters. Br. Med. J. 1, 14181421.
  • Atouf F., Czernichow P. and Scharfmann R. (1997) Expression of neuronal traits in pancreatic beta cells. Implication of neuron-restrictive silencing factor/repressor element silencing transcription factor, a neuron-restrictive silencer. J. Biol. Chem. 272, 19291934.
  • Bacos K., Bjorkqvist M., Petersen A. et al. (2008) Islet β-cell area and hormone expression are unaltered in Huntington's disease. Histochem. Cell Biol. 129, 623629.
  • Barthson J., Germano C. M., Moore F. et al. (2011) Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation. J. Biol. Chem. 286, 3963239643.
  • Bergman R. N., Prager R., Volund A. and Olefsky J. M. (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 79, 790800.
  • Bird T. D., Turner J. L., Sumi S. M. and Bierman E. L. (1978) Abnormal function of endocrine pancreas and anterior pituitary in Friedreich's ataxia. Studies in a family. Ann. Intern. Med. 88, 478481.
  • Bjorkqvist M., Fex M., Renstrom E. et al. (2005) The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient β-cell mass and exocytosis. Hum. Mol. Genet. 14, 565574.
  • Brunelle J. K. and Letai A. (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell Sci. 122, 437441.
  • Brunmair B., Staniek K., Gras F. et al. (2004) Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53, 10521059.
  • Butler P. C., Meier J. J., Butler A. E. and Bhushan A. (2007) The replication of β cells in normal physiology, in disease and for therapy. Nat. Clin. Pract. Endocrinol. Metab. 3, 758768.
  • Campuzano V., Montermini L., Molto M. D. et al. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 14231427.
  • Cnop M., Vidal J., Hull R. L. et al. (2007) Progressive loss of β-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 30, 677682.
  • Cnop M., Hughes S. J., Igoillo-Esteve M. et al. (2010) The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53, 321330.
  • Cnop M., Foufelle F. and Velloso L. A. (2012a) Endoplasmic reticulum stress, obesity and diabetes. Trends Mol. Med. 18, 5968.
  • Cnop M., Igoillo-Esteve M., Rai M. et al. (2012b) Central role and mechanisms of β cell dysfunction and death in Friedreich ataxia-associated diabetes. Ann. Neurol. 72, 971982.
  • Colli M. L., Nogueira T. C., Allagnat F., Cunha D. A., Gurzov E. N., Cardozo A. K., Roivainen M., Op de Beeck A. and Eizirik D. L. (2011) Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic β cell apoptosis via a Bim / Mcl-1 imbalance. PLoS Pathog. 7, e1002267.
  • Coppola G., Choi S. H., Santos M. M., Miranda C. J., Tentler D., Wexler E. M., Pandolfo M. and Geschwind D. H. (2006) Gene expression profiling in frataxin deficient mice: microarray evidence for significant expression changes without detectable neurodegeneration. Neurobiol. Dis. 22, 302311.
  • Coppola G., Marmolino D., Lu D. et al. (2009) Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich's ataxia. Hum. Mol. Genet. 18, 24522461.
  • Cossee M., Durr A., Schmitt M. et al. (1999) Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann. Neurol. 45, 200206.
  • Cunha D. A., Igoillo-Esteve M., Gurzov E. N. et al. (2012) Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes 61, 27632775.
  • De Michele G., Perrone F., Filla A., Mirante E., Giordano M., De Placido S. and Campanella G. (1996) Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: a retrospective study on 119 patients. Neurology, 47, 12601264.
  • Delatycki M. B., Paris D. B., Gardner R. J. et al. (1999) Clinical and genetic study of Friedreich ataxia in an Australian population. Am. J. Med. Genet. 87, 168174.
  • Du J., Campau E., Soragni E., Ku S., Puckett J. W., Dervan P. B. and Gottesfeld J. M. (2012) Role of mismatch repair enzymes in GAA.TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells. J. Biol. Chem. 287, 2986129872.
  • Durr A., Cossee M., Agid Y., Campuzano V., Mignard C., Penet C., Mandel J. L., Brice A. and Koenig M. (1996) Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335, 11691175.
  • Fantus I. G., Janjua N., Senni H. and Andermann E. (1991) Glucose intolerance in first-degree relatives of patients with Friedreich's ataxia is associated with insulin resistance: evidence for a closely linked inherited trait. Metabolism 40, 788793.
  • Fantus I. G., Seni M. H. and Andermann E. (1993) Evidence for abnormal regulation of insulin receptors in Friedreich's ataxia. J. Clin. Endocrinol. Metab. 76, 6063.
  • Filla A., De Michele G., Cavalcanti F., Pianese L., Monticelli A., Campanella G. and Cocozza S. (1996) The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am. J. Hum. Genet. 59, 554560.
  • Finocchiaro G., Baio G., Micossi P., Pozza G. and di Donato S. (1988) Glucose metabolism alterations in Friedreich's ataxia. Neurology 38, 12921296.
  • Gakh O., Bedekovics T., Duncan S. F., Smith D. Y. T., Berkholz D. S. and Isaya G. (2010) Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly. J. Biol. Chem. 285, 3848638501.
  • Gross A., Jockel J., Wei M. C. and Korsmeyer S. J. (1998) Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 38783885.
  • Gurzov E. N. and Eizirik D. L. (2011) Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction. Trends Cell Biol. 21, 424431.
  • Gurzov E. N., Ortis F., Cunha D. A., Gosset G., Li M., Cardozo A. K. and Eizirik D. L. (2009) Signaling by IL-1β+IFNγ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ. 16, 15391550.
  • Gurzov E. N., Germano C. M., Cunha D. A., Ortis F., Vanderwinden J. M., Marchetti P., Zhang L. and Eizirik D. L. (2010) p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic β-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J. Biol. Chem. 285, 1991019920.
  • Harding A. E. (1981) Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104, 589620.
  • Hewer R. L. (1968) Study of fatal cases of Friedreich's ataxia. Br. Med. J. 3, 649652.
  • Hewer R. L. and Robinson N. (1968) Diabetes mellitus in Friedreich's ataxia. J. Neurol. Neurosurg. Psychiatry 31, 226231.
  • Holst J. J., Burcelin R. and Nathanson E. (2011) Neuroprotective properties of GLP-1: theoretical and practical applications. Curr. Med. Res. Opin. 27, 547558.
  • Hotchkiss R. S., Strasser A., McDunn J. E. and Swanson P. E. (2009) Cell death. N. Engl. J. Med. 361, 15701583.
  • Igoillo-Esteve M., Marselli L., Cunha D. A. et al. (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53, 13951405.
  • Jiralerspong S., Ge B., Hudson T. J. and Pandolfo M. (2001) Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells. FEBS Lett. 509, 101105.
  • Kahn S. E. (2003) The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46, 319.
  • Kahn S. E., Prigeon R. L., McCulloch D. K. et al. (1993) Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42, 16631672.
  • Kakhlon O., Manning H., Breuer W., Melamed-Book N., Lu C., Cortopassi G., Munnich A. and Cabantchik Z. I. (2008) Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation. Blood 112, 52195227.
  • Khan R. J., Andermann E. and Fantus I. G. (1986) Glucose intolerance in Friedreich's ataxia: association with insulin resistance and decreased insulin binding. Metabolism 35, 10171023.
  • Kim H., Rafiuddin-Shah M., Tu H. C., Jeffers J. R., Zambetti G. P., Hsieh J. J. and Cheng E. H. (2006) Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 8, 13481358.
  • Kim H., Tu H. C., Ren D., Takeuchi O., Jeffers J. R., Zambetti G. P., Hsieh J. J. and Cheng E. H. (2009) Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell 36, 487499.
  • Koeppen A. H. (2011) Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J. Neurol. Sci. 303, 112.
  • Ku S., Soragni E., Campau E., Thomas E. A., Altun G., Laurent L. C., Loring J. F., Napierala M. and Gottesfeld J. M. (2010) Friedreich's ataxia induced pluripotent stem cells model intergenerational GAATTC triplet repeat instability. Cell Stem Cell 7, 631637.
  • Lee J. W., Kim W. H., Lim J. H., Song E. H., Song J., Choi K. Y. and Jung M. H. (2009) Mitochondrial dysfunction: glucokinase downregulation lowers interaction of glucokinase with mitochondria, resulting in apoptosis of pancreatic β-cells. Cell. Signal. 21, 6978.
  • Letai A. (2009) Puma strikes Bax. J. Cell Biol. 185, 189191.
  • Liu J., Verma P. J., Evans-Galea M. V. et al. (2011) Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev. 7, 703713.
  • Lodi R., Cooper J. M., Bradley J. L., Manners D., Styles P., Taylor D. J. and Schapira A. H. (1999) Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc. Natl Acad. Sci. USA 96, 1149211495.
  • Lu C. and Cortopassi G. (2007) Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts. Arch. Biochem. Biophys. 457, 111122.
  • Lu C., Schoenfeld R., Shan Y., Tsai H. J., Hammock B. and Cortopassi G. (2009) Frataxin deficiency induces Schwann cell inflammation and death. Biochim. Biophys. Acta 1792, 10521061.
  • Maechler P. and Wollheim C. B. (2001) Mitochondrial function in normal and diabetic β-cells. Nature 414, 807812.
  • Mateo I., Llorca J., Volpini V., Corral J., Berciano J. and Combarros O. (2004) Expanded GAA repeats and clinical variation in Friedreich's ataxia. Acta Neurol. Scand. 109, 7578.
  • Meyer C., Carlqvist H., Vorgerd M., Schols L., Ostenson C. G. and Ristow M. (2006) Regular insulin secretory oscillations despite impaired ATP synthesis in Friedreich Ataxia patients. Horm. Metab. Res. 38, 683687.
  • Miranda C. J., Santos M. M., Ohshima K. et al. (2002) Frataxin knockin mouse. FEBS Lett. 512, 291297.
  • Montermini L., Richter A., Morgan K. et al. (1997) Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann. Neurol. 41, 675682.
  • Muhlenhoff U., Richhardt N., Ristow M., Kispal G. and Lill R. (2002) The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum. Mol. Genet. 11, 20252036.
  • Mulder H. and Ling C. (2009) Mitochondrial dysfunction in pancreatic β-cells in type 2 diabetes. Mol. Cell. Endocrinol. 297, 3440.
  • Napoli E., Morin D., Bernhardt R., Buckpitt A. and Cortopassi G. (2007) Hemin rescues adrenodoxin, heme a and cytochrome oxidase activity in frataxin-deficient oligodendroglioma cells. Biochim. Biophys. Acta 1772, 773780.
  • Owen M. R., Doran E. and Halestrap A. P. (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348(Pt 3), 607614.
  • Paupe V., Dassa E. P., Goncalves S., Auchere F., Lonn M., Holmgren A. and Rustin P. (2009) Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS ONE 4, e4253.
  • Perl S., Kushner J. A., Buchholz B. A. et al. (2010) Significant human β-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J. Clin. Endocrinol. Metab. 95, E234E239.
  • Petersen K. F., Dufour S., Befroy D., Garcia R. and Shulman G. I. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664671.
  • Puccio H., Simon D., Cossee M. et al. (2001) Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet. 27, 181186.
  • Rahier J., Guiot Y., Goebbels R. M., Sempoux C. and Henquin J. C. (2008) Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes Obes. Metab. 10, 3242.
  • Ristow M. (2004) Neurodegenerative disorders associated with diabetes mellitus. J. Mol. Med. 82, 510529.
  • Ristow M., Pfister M. F., Yee A. J. et al. (2000) Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc. Natl Acad. Sci. USA 97, 1223912243.
  • Ristow M., Mulder H., Pomplun D. et al. (2003) Frataxin deficiency in pancreatic islets causes diabetes due to loss of β cell mass. J. Clin. Invest. 112, 527534.
  • Santos M. M., Ohshima K. and Pandolfo M. (2001) Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm. Hum. Mol. Genet. 10, 19351944.
  • Schoenle E. J., Boltshauser E. J., Baekkeskov S., Landin Olsson M., Torresani T. and von Felten A. (1989) Preclinical and manifest diabetes mellitus in young patients with Friedreich's ataxia: no evidence of immune process behind the islet cell destruction. Diabetologia 32, 378381.
  • Shapcott D., Melancon S., Butterworth R. F., Khoury K., Collu R., Breton G., Geoffroy G., Lemieux B. and Barbeau A. (1976) Glucose and insulin metabolism in Friedreich's ataxia. Can. J. Neurol. Sci. 3, 361364.
  • Simon D., Seznec H., Gansmuller A., Carelle N., Weber P., Metzger D., Rustin P., Koenig M. and Puccio H. (2004) Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J. Neurosci. 24, 19871995.
  • Singh S., Loke Y. K. and Furberg C. D. (2007) Thiazolidinediones and heart failure: a teleo-analysis. Diabetes Care 30, 21482153.
  • Smith R., Bacos K., Fedele V. et al. (2009) Mutant huntingtin interacts with β-tubulin and disrupts vesicular transport and insulin secretion. Hum. Mol. Genet. 18, 39423954.
  • Spalding K. L., Bhardwaj R. D., Buchholz B. A., Druid H. and Frisen J. (2005) Retrospective birth dating of cells in humans. Cell 122, 133143.
  • Stehling O., Elsasser H. P., Bruckel B., Muhlenhoff U. and Lill R. (2004) Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum. Mol. Genet. 13, 30073015.
  • Thierbach R., Schulz T. J., Isken F. et al. (2005) Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum. Mol. Genet. 14, 38573864.
  • Thomas H. E. and Kay T. W. (2011) Intracellular pathways of pancreatic β-cell apoptosis in type 1 diabetes. Diabetes Metab. Res. Rev. 27, 790796.
  • Thoren C. (1962) Diabetes mellitus in Friedreich's ataxia. Acta Paediatr. Suppl. 135, 239247.
  • Tolis G., Mehta A., Andermann E., Harvey C. and Barbeau A. (1980) Friedreich's ataxia and oral glucose tolerance: I. The effect of ingested glucose on serum glucose and insulin values in homozygotes, obligate heterozygotes and potential carriers of the Friedreich's ataxia gene. Can. J. Neurol. Sci. 7, 397400.
  • Vorgerd M., Schols L., Hardt C., Ristow M., Epplen J. T. and Zange J. (2000) Mitochondrial impairment of human muscle in Friedreich ataxia in vivo. Neuromuscul. Disord. 10, 430435.
  • Wiederkehr A. and Wollheim C. B. (2012) Mitochondrial signals drive insulin secretion in the pancreatic β-cell. Mol. Cell. Endocrinol. 353, 128137.
  • Wong A., Yang J., Cavadini P., Gellera C., Lonnerdal B., Taroni F. and Cortopassi G. (1999) The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet. 8, 425430.
  • Youle R. J. and Strasser A. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 4759.